Application note: Measure cancer cell viability using a homogeneous, stable luminescence assay
Posted: 29 November 2019 | Molecular Devices | No comments yet
Learn how to screen for cell viability with the CellTiter-Glo assay on the SpectraMax® iD5 Multi-Mode Microplate Reader.
Luminescent cell viability assays use the firefly luciferase reaction as a way to determine the relative numbers of living cells under different treatments or experimental conditions. Metabolically active cells produce ATP, which is required by the luciferase reaction. When ATP is the limiting component in the reaction, the amount of light produced is proportional to, and serves as the readout for, the number of viable cells.
In this application note, scientists from Molecular Devices validated the performance of Promega’s CellTiter-Glo 2.0 Cell Viability Assay on the SpectraMax® iD5 Multi-Mode Microplate Reader. Both ATP and viable cells were used to generate standard curves demonstrating the sensitivity and linearity of the assay.
- Highly sensitive luminescence detection down to 20 cells per well
- Easy correlation of cell number and ATP content
- Convenient single-reagent workflow
Related content from this organisation
- Application note: Measure viral-induced cytopathic effects with a quantitative luminescence assay
- Application note: High-throughput IgG quantitation platform for clone screening during drug discovery and development
- ebook: Optimise your high value cell lines
- ebook: Accelerate vaccine development
- Video: Imaging and analysis of a 3D airway organoid model
Related organisations
Molecular Devices
